MOR (95%CI) | Model 0 | Model 1 | Model 2 | |||
---|---|---|---|---|---|---|
 | - | Age, gender | Age, gender, SES, ethnicity and urbanization level | |||
 | Network | Practice | Network | Practice | Network | Practice |
Diabetes mellitus | 1.20 | 1.49 | 1.20 | 1.48 | 1.13 | 1.40 |
 | 1.08-1.61 | 1.43-1.53 | 1.07-1.58 | 1.43-1.53 | 1.04-1.39 | 1.35-1.44 |
Depression | 1.58 | 1.70 | 1.58 | 1.72 | 1.53 | 1.70 |
 | 1.27-3.05 | 1.61-1.79 | 1.27-3.06 | 1.64-1.81 | 1.24-2.84 | 1.61-1.78 |
Anxiety disorder | 1.64 | 1.73 | 1.64 | 1.74 | 1.53 | 1.73 |
 | 1.29-3.32 | 1.65-1.82 | 1.29-3.30 | 1.65-1.83 | 1.22-2.87 | 1.64-1.83 |
Stroke | 1.85 | 1.78 | 1.81 | 1.73 | 1.82 | 1.72 |
 | 1.42-4.28 | 1.74-1.88 | 1.40-4.08 | 1.70-1.83 | 1.40-4.20 | 1.69-1.83 |
CHD | 1.78 | 1.86 | 1.72 | 1.85 | 1.60 | 1.85 |
 | 1.35-4.57 | 1.75-1.97 | 1.33-4.20 | 1.82-1.96 | 1.27-3.55 | 1.82-1.96 |
COPD | 1.35 | 1.65 | 1.33 | 1.63 | 1.30 | 1.60 |
 | 1.14-2.14 | 1.57-1.73 | 1.13-2.08 | 1.61-1.70 | 1.11-1.95 | 1.58-1.68 |
Asthma | 1.29 | 1.59 | 1.30 | 1.58 | 1.24 | 1.61 |
 | 1.13-1.91 | 1.52-1.66 | 1.13-1.93 | 1.52-1.65 | 1.08-1.73 | 1.54-1.68 |
Dermatitis | 1.76 | 1.56 | 1.76 | 1.56 | 1.79 | 1.58 |
 | 1.39-3.72 | 1.50-1.62 | 1.39-3.73 | 1.50-1.63 | 1.40-3.89 | 1.51-1.64 |
Osteoarthritis | 1.86 | 1.62 | 1.89 | 1.59 | 1.88 | 1.58 |
 | 1.43-4.32 | 1.54-1.70 | 1.45-4.47 | 1.57-1.66 | 1.44-4.37 | 1.56-1.66 |
Neck and back problems | 2.26 | 1.39 | 2.33 | 1.42 | 2.39 | 1.41 |
 | 1.63-6.44 | 1.35-1.43 | 1.66-6.94 | 1.38-1.47 | 1.68-7.32 | 1.37-1.45 |